Cystine-knot polypeptides: Cloaked-2 molecules and uses thereof
AssigneeAmgen Inc.
InventorsChristopher Paszty, Yongming Gao
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel Cloaked-2 polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, selective binding agents, and methods for producing Cloaked-2 polypeptides. Also provided for are methods for the treatment, diagnosis, amelioration, or prevention of diseases with Cloaked-2 polypeptides.
Claims5
1-62. (canceled)
A method for treating, preventing, or ameliorating a disease, condition, or disorder comprising administering to a patient an effective amount of a selective binding agent or fragment thereof that specifically binds at least one polypeptide wherein said polypeptide comprises the amino acid sequence selected from the group consisting of:
- a) the amino acid sequence as set forth in SEQ ID NO:
- 2 or SEQ ID NO:
- 4;
- and
- b) a fragment of the amino acid sequence set forth in at least one of SEQ ID NO:
- 2 or SEQ ID NO:
- 4;
- and
- c) a naturally occurring variant of (a) or (b).
A method for treating, preventing or ameliorating a medical condition comprising administering to a patient an isolated polypeptide encoded by the nucleotide sequence selected from the group consisting of:
- a) the nucleotide sequence as set forth in SEQ ID NO:
- 1 or SEQ ID NO:
- 3;
- b) a nucleotide sequence encoding the polypeptide as set forth in SEQ ID NO:
- 2 or SEQ ID NO:
- 4;
- c) a nucleotide sequence that hybridizes under moderately or highly stringent conditions to the complement of (a) or (b), wherein the encoded polypeptide has an activity of the polypeptide as set forth in SEQ ID NO:
- 2 or SEQ ID NO:
- 4;
- and
- d) a nucleotide sequence complementary to any of (a)-(c).
A method for treating, preventing or ameliorating a medical condition comprising administering to a patient an isolated polypeptide comprising the amino acid sequence set forth in SEQ ID NO:
- 2 or SEQ ID NO:
- 4.
A method of modulating levels of a polypeptide in an animal comprising administering to the animal an isolated nucleic acid molecule comprising a nucleotide sequence selected from the group consisting of:
- (a) the nucleotide sequence as set forth in SEQ ID NO:
- 1 or SEQ ID NO:
- 3;
- (b) a nucleotide sequence encoding the polypeptide as set forth in SEQ ID NO:
- 2 or SEQ ID NO:
- 4;
- (c) a nucleotide sequence which hybridizes under moderately or highly stringent conditions to the complement of (a) or (b), wherein the encoded polypeptide has an activity of the polypeptide as set forth in SEQ ID NO:
- 2 or SEQ ID NO:
- 4;
- and
- (d) a nucleotide sequence complementary to any of (a)-(c).
Dependencies are inferred from the claim text.